New letters urge the Centers for Medicare & Medicaid Services to expand Medicare and Medicaid to include FDA-approved ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...

Home health agencies (HHAs) owned by private equity (PE) firms tend to outperform agencies not owned by PE in certain metrics while lagging in others.

Premier has called on CMS to enhance Medicare Advantage and Part D policies for 2026, emphasizing policies to protect access to care, particularly in rural areas.

CMS issued the industry-wide ratings the next month. Among large insurers, UnitedHealthcare experienced one of the most ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — ...

Given forthcoming changes to Medicare Part D plans under the Inflation Reduction Act, CMS should collect and publish ...

An expanding prohibition on third-party financial guarantees could lead to more nursing home using lawsuits to collect unpaid ...

The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

The Centers for Medicare & Medicaid Services has changed course on plans to appeal a court ruling that determined it must ...